Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort
Conditions: Influenza; Hepatitis A; Typhoid; Healthy Adults Interventions: Biological: Fluzone® quadrivalent; Biological: Fluzone High Dose; Biological: Fluad; Biological: Vaqta; Biological: Typhim Vi; Biological: Vivotif Sponsors: Stanford University; National Institute of Allergy and Infectious Diseases (NIAID) Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2017 Category: Research Source Type: clinical trials